AC-262536

Also known as: AC-262,536, Accadine, Accadrine

Unknown

Classification

Sarm

Regulatory Status

not-established

Overview

Preclinical literature describes AC-262536 as a non-steroidal selective androgen receptor partial agonist with tissue-selective anabolic signals in rodent models. Human mechanism and clinical effect are not established.

Evidence and limitations

Human/preclinical evidence breakdown is not available in this record.

Pathways

androgen-receptor-signalingselective androgen receptor modulatorandrogen-receptor partial agonistandrogen receptor

Interactions & cautions

Drug interactions

other androgens, anabolic steroids, or SARMs — Additive androgen-receptor activity and unknown stacked toxicity are plausible; no specific interaction trials exist. (high)

These are observational flags for review, not individualized instructions.

Sources

https://www.fda.gov/consumers/consumer-updates/fda-warns-use-selective-androgen-receptor-modulators-sarms-among-teens-young-adults (opens in a new tab)
https://pubmed.ncbi.nlm.nih.gov/18164613/ (opens in a new tab)

Educational reference only — not medical advice.